Stock CELU CELULARITY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Celularity Inc.

Equities

CELU

US1511902041

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
3.11 USD +4.36% Intraday chart for Celularity Inc. -10.12% +25.71%
May. 21 Transcript : Celularity Inc. - Analyst/Investor Day
Mar. 26 Celularity Receives Healthcare Common Procedure Coding System Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance 3L CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CELULARITY INC. Stock Celularity Inc.
 67.74M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. CELU Stock
  4. Charts Celularity Inc.
  5. Sector Chart